Regis Resources (ASX: RRL) drops Vault Minerals bid, letting Genesis Minerals’s A$5.6bn offer proceed
Read More Pharma Industry News Krystal Biotech stock jumps after FDA expands Vyjuvek label to newborns and at-home use Krystal Biotech stock surged after the FDA expanded Vyjuvek’s label to newborns and caregiver use, boosting adoption potential and investor confidence. byPallavi MadhirajuSeptember 15, 2025